Cargando…
Surfactant replacement therapy for respiratory distress syndrome in preterm infants: United Kingdom national consensus
Autores principales: | Banerjee, Sujoy, Fernandez, Ramon, Fox, Grenville F., Goss, Kevin C. W., Mactier, Helen, Reynolds, Peter, Sweet, David G., Roehr, Charles C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760556/ https://www.ncbi.nlm.nih.gov/pubmed/30780152 http://dx.doi.org/10.1038/s41390-019-0344-5 |
Ejemplares similares
-
Aerosolized Surfactant for Preterm Infants with Respiratory Distress Syndrome
por: Brasher, Mandy, et al.
Publicado: (2021) -
Effect of surfactant dose on outcomes in preterm infants with respiratory distress syndrome: the OPTI-SURF study protocol
por: Goss, Kevin Colin William, et al.
Publicado: (2020) -
Trial of aerosolised surfactant for preterm infants with respiratory distress syndrome
por: Jardine, Luke, et al.
Publicado: (2022) -
Early Surfactant Therapy for Respiratory Distress Syndrome in Very Preterm Infants
por: Cucerea, Manuela, et al.
Publicado: (2023) -
Comment on “A Pumpless Microfluidic Neonatal Lung Assist Device for Support of Preterm Neonates in Respiratory Distress”
por: Wang, Li, et al.
Publicado: (2021)